Literature DB >> 9035364

Tyrosine phosphorylation of measles virus P-phosphoprotein in persistently infected neuroblastoma cells.

R Ofir1, Y Weinstein, E Bazarsky, S Blagerman, M Wolfson, T Hunter, B Rager-Zisman.   

Abstract

Replication and encapsidation of measles virus (MV) requires the interaction between the nuclear protein (N) and the phosphoprotein (P). It is known that both proteins are phosphorylated on serine and threonine residues. Recently we have shown that N is phosphorylated on tyrosine in persistently-infected mouse neuroblastoma cells (NS20Y/MS). Here, we show that P in NS20Y/MS is also phosphorylated on tyrosine. To investigate whether cellular tyrosine kinases can bind and phosphorylate P, a solid phase kinase assay was employed. We show that bacterially-expressed MV P fragments, were phosphorylated on tyrosine by purified mouse c-Src protein-tyrosine kinase and when mixed with uninfected neuroblastoma cell (NS20Y) extracts, these P fragments were phosphorylated on tyrosine in addition to serine and threonine. These results imply that MV P is a substrate for tyrosine phosphorylation by cellular tyrosine kinase(s).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9035364     DOI: 10.1007/bf00366980

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  20 in total

1.  A protein tyrosine kinase in the interferon alpha/beta signaling pathway.

Authors:  L Velazquez; M Fellous; G R Stark; S Pellegrini
Journal:  Cell       Date:  1992-07-24       Impact factor: 41.582

2.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

3.  A transcription factor with SH2 and SH3 domains is directly activated by an interferon alpha-induced cytoplasmic protein tyrosine kinase(s).

Authors:  X Y Fu
Journal:  Cell       Date:  1992-07-24       Impact factor: 41.582

4.  Structural phosphoproteins associated with measles virus nucleocapsids from persistently infected cells.

Authors:  S J Robbins; J A Fenimore; R H Bussell
Journal:  J Gen Virol       Date:  1980-06       Impact factor: 3.891

5.  Measles virus phosphoprotein retains the nucleocapsid protein in the cytoplasm.

Authors:  M Huber; R Cattaneo; P Spielhofer; C Orvell; E Norrby; M Messerli; J C Perriard; M A Billeter
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

6.  Altered ratios of measles virus transcripts in diseased human brains.

Authors:  R Cattaneo; G Rebmann; K Baczko; V ter Meulen; M A Billeter
Journal:  Virology       Date:  1987-10       Impact factor: 3.616

7.  Spontaneous and differentiation-dependent regulation of measles virus gene expression in human glial cells.

Authors:  S Schneider-Schaulies; J Schneider-Schaulies; M Bayer; S Löffler; V ter Meulen
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

8.  Tyrosine phosphorylation of measles virus nucleocapsid protein in persistently infected neuroblastoma cells.

Authors:  Y Segev; R Ofir; S Salzberg; A Heller; Y Weinstein; N Isakov; S Udem; M Wolfson; B Rager-Zisman
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

9.  Isolation of cold-sensitive mutants of measles virus from persistently infected murine neuroblastoma cells.

Authors:  B Rager-Zisman; J E Egan; Y Kress; B R Bloom
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

10.  Nucleoprotein phosphorylated on both serine and threonine is preferentially assembled into the nucleocapsids of measles virus.

Authors:  A F Gombart; A Hirano; T C Wong
Journal:  Virus Res       Date:  1995-06       Impact factor: 3.303

View more
  2 in total

1.  Persistent measles virus infection of murine neuroblastoma cells differentially affects the expression of PKC individual isoenzymes.

Authors:  E Bazarsky; M Wolfson; D Galron; Y Granot; S Argov; N Isakov; B Rager-Zisman
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

2.  Phosphorylation events during viral infections provide potential therapeutic targets.

Authors:  Julie A Keating; Rob Striker
Journal:  Rev Med Virol       Date:  2011-11-24       Impact factor: 6.989

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.